期刊
FRONTIERS IN IMMUNOLOGY
卷 12, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.738312
关键词
immunotherapy; transplantation; autoimmunity; cancer; meeting report
类别
资金
- Labex IGO project part of the Investissements dAvenir French Government program [ANR-11-LABX-0016-01]
- Fondation Progreffe
- Fondation ARSEP
- SFR Francois Bonamy
- Centre Hospitalier Universitaire Nantes
- Inserm
- Universite de Nantes
- Universite Bretagne Loire
- Astellas
- Fluidigm
- Novartis
- OSE Immunotherapeutics
- Institut Merieux
- Promega
- Sandoz
- Stem Cell
- Beckman-Coulter
- Bristol-Myers-Squibb
- Cytek
- Nanostring
- Myltenyi
- Xenothera
- Cellectis
The 24th annual NAT conference and the 4th biennial LabEx IGO meeting were held jointly around the theme of new horizons in immunotherapy, highlighting new findings in the fields of transplantation, autoimmunity, and cancer on May 31st and June 1st, 2021.
The 24th edition of the annual NAT conference (Nantes Actualites Transplantation) and the 4th edition of the biennial LabEx IGO meeting (Immunotherapy Graft Oncology) were held jointly around a common theme: New horizons in immunotherapy, on May 31st and June 1st 2021 to highlight new findings in the fields of transplantation, autoimmunity and cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
